Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Bacterial outer membrane lipopolysaccharide (LPS) is a large amphipathic glycolipid that forms the major component of the external leaflet of the outer membrane in virtually all Gram-negative bacteria. It consists structurally of three main regions: 1. Lipid A – The hydrophobic anchor embedded within the bacterial outer membrane; responsible for most toxic effects (“endotoxin” activity). 2. Core oligosaccharide – A short sugar chain attached directly to lipid A. 3. O-antigen polysaccharide – A highly variable repeating glycan polymer extending outward from the cell surface; determines antigenic specificity between strains. LPS plays essential roles in maintaining structural integrity and protecting bacteria from hostile environments, including antibiotics and host immune factors. In mammals, recognition by innate immune receptors—primarily Toll-like receptor 4—triggers robust inflammatory responses that are protective at low levels but can cause severe pathology such as septic shock when uncontrolled. Because it is essential for viability in most Gram-negative pathogens and central to their interaction with hosts, bacterial outer membrane lipopolysaccharide is considered both a key virulence factor and an important therapeutic target—especially for drug development aimed at disrupting its synthesis/transport or neutralizing its toxic effects during infection.[1][2][3][4][7]
For drugs that interact with this molecule: Disruption of outer membrane integrity by binding to lipid A region, leading to increased permeability and cell death (e.g., polymyxins)[9] For host response modulation: Neutralization/blockade of endotoxin activity to prevent excessive immune activation/sepsis
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Bacterial outer membrane lipopolysaccharide (LPS).